We're committed to reducing the incidence of melanoma for all Australians, by creating a network of advanced 3D imaging technology systems that will improve early detection and diagnosis, particularly within regional areas.
ACRF ACEMID brings together three leading Australian universities in skin research; The University of Sydney, The University of Queensland and Monash University in Victoria.
Our goal is to integrate and leverage world-class research expertise that is unique to Australia, to provide technologically disruptive and reliable solutions for the early diagnosis of melanoma.
Together, we're creating a 3D total body skin imaging network, which will form an interconnected centre of excellence in diagnostic imaging of early melanoma.
Project update: The ACRF ACEMID project have received a wonderful response from the community to participate in our research, we have received over 3500 expressions of interest for NSW since our National Launch took place in September 2021. The ACEMID team would like to thank everyone for their willingness to contribute to this important work.
At the end of March 22, our active site has recruited 289 participants into our study and our team is working with eHealth NSW and Local Health Districts to open more sites in 2022 to build capacity for the project.
In partnership with eHealth NSW, our project will deliver teledermatology with Local Health Services, providing a connected and far-reaching early melanoma detection technology and program.
The total body 3D imaging technology at the core of ACRF ACEMID will allow for objective and secure collection of surface photography in a few milliseconds. The generated avatars enable documentation of all skin surfaces (except soles of feet, scalp and areas covered by clothing) to unprecedented levels of detail.
Sequential photography at regular intervals will allow for the detection of new or changing lesions. This detailed photography, coupled with Artificial Intelligence (being developed by the consortium) will allow the implementation of quick and cost-effective skin screening and a reduction of melanoma incidence.
The research and clinical strength underpinning the proposed ACRF ACEMID initiative include three complementary NHMRC-funded Centres of Research Excellence (CRE):
View a diagram of the ACEMID research structure (png, 289kb)
The goals of the ACRF ACEMID cohort study is to:
Melanoma Institute Australia (MIA)
The Poche Centre, 40 Rocklands Rd, Wollstonecraft NSW 2065 (opposite the Mater Hospital)
Phone: (02) 9911 7200
Western Sydney Local Health District (WSLHD) – Westmead Hospital
Dermatology Department (Block D5a), Westmead Hospital, Cnr Darcy Rd & Hawkesbury Rd, Westmead, NSW 2145
Phone: (02) 8890 7149
Sydney Local Health District (SLHD) – Royal Prince Alfred Hospital – Sydney Melanoma Diagnostic Centre (SMDC) – Coming soon
Sydney Melanoma Diagnostic Centre (SMDC) Royal Prince Alfred Hospital, Level 2, Gloucester House, Sydney Cancer Centre, Missenden Rd, Camperdown NSW 2050
Phone: (02) 9515 8537